Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
Aim. To study clinical efficacy of a new, class III, antiarrhythmic agent, nibentan, in various supraventricular (SV) cardiac arrythmias. Material and methods. In total, 153 patients with atrial fibrillation, atrial flutter, or SV tachycardia were examined. Electrocardiography monitoring, echocardio...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2005-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041373110042624 |
|---|---|
| author | V. G. Valiev A. E. Radzevich V. A. Gorshkov E. M. Zeltyn A. B. Besprozvanny E. N. Ostroumov |
| author_facet | V. G. Valiev A. E. Radzevich V. A. Gorshkov E. M. Zeltyn A. B. Besprozvanny E. N. Ostroumov |
| author_sort | V. G. Valiev |
| collection | DOAJ |
| description | Aim. To study clinical efficacy of a new, class III, antiarrhythmic agent, nibentan, in various supraventricular (SV) cardiac arrythmias. Material and methods. In total, 153 patients with atrial fibrillation, atrial flutter, or SV tachycardia were examined. Electrocardiography monitoring, echocardiography, electrolyte balance assessment, biochemical blood assay were performed. Left ventricular (LV) kinetics and perfusion was measured by myocardial computer scintigraphy method. The results were processed with 4DM spect program. Results. Nibentan demonstrated high antiarrhythmic activity in various SV cardiac arrhythmias No significant effects on central hemodynamics and LV myocardial perfusion were observed. Conclusion. In this trial, a new medication, nibentan, demonstrated the qualities of a true class III antiarrhythmic agent. |
| format | Article |
| id | doaj-art-8d4907d427234348b5cae923e20366e6 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2005-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-8d4907d427234348b5cae923e20366e62025-08-20T02:55:48Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252005-12-0146, ч.II7076756Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia managementV. G. Valiev0A. E. Radzevich1V. A. Gorshkov2E. M. Zeltyn3A. B. Besprozvanny4E. N. Ostroumov5Moscow City Clinical Hospital No. 52Moscow City Clinical Hospital No. 52Moscow State Medico-Stomatological UniversityMoscow State Medico-Stomatological UniversityMoscow City Clinical Hospital No. 52Research Institute of Transplantology and Artificial Organs, MoscowAim. To study clinical efficacy of a new, class III, antiarrhythmic agent, nibentan, in various supraventricular (SV) cardiac arrythmias. Material and methods. In total, 153 patients with atrial fibrillation, atrial flutter, or SV tachycardia were examined. Electrocardiography monitoring, echocardiography, electrolyte balance assessment, biochemical blood assay were performed. Left ventricular (LV) kinetics and perfusion was measured by myocardial computer scintigraphy method. The results were processed with 4DM spect program. Results. Nibentan demonstrated high antiarrhythmic activity in various SV cardiac arrhythmias No significant effects on central hemodynamics and LV myocardial perfusion were observed. Conclusion. In this trial, a new medication, nibentan, demonstrated the qualities of a true class III antiarrhythmic agent.https://cardiovascular.elpub.ru/jour/article/view/1043atrial fibrillationatrial flutterclass iii antiarrhythmic agentnibentan |
| spellingShingle | V. G. Valiev A. E. Radzevich V. A. Gorshkov E. M. Zeltyn A. B. Besprozvanny E. N. Ostroumov Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management Кардиоваскулярная терапия и профилактика atrial fibrillation atrial flutter class iii antiarrhythmic agent nibentan |
| title | Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management |
| title_full | Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management |
| title_fullStr | Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management |
| title_full_unstemmed | Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management |
| title_short | Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management |
| title_sort | clinical study of russian class iii antiarrhythmic agent nibentan in supraventricular arrhythmia management |
| topic | atrial fibrillation atrial flutter class iii antiarrhythmic agent nibentan |
| url | https://cardiovascular.elpub.ru/jour/article/view/1043 |
| work_keys_str_mv | AT vgvaliev clinicalstudyofrussianclassiiiantiarrhythmicagentnibentaninsupraventriculararrhythmiamanagement AT aeradzevich clinicalstudyofrussianclassiiiantiarrhythmicagentnibentaninsupraventriculararrhythmiamanagement AT vagorshkov clinicalstudyofrussianclassiiiantiarrhythmicagentnibentaninsupraventriculararrhythmiamanagement AT emzeltyn clinicalstudyofrussianclassiiiantiarrhythmicagentnibentaninsupraventriculararrhythmiamanagement AT abbesprozvanny clinicalstudyofrussianclassiiiantiarrhythmicagentnibentaninsupraventriculararrhythmiamanagement AT enostroumov clinicalstudyofrussianclassiiiantiarrhythmicagentnibentaninsupraventriculararrhythmiamanagement |